Cardiac mapping is one of the advanced techniques associated with the collection and display of data gathered from an electrocardiogram. It is characterized as a process involving identification of spatial and temporal distribution of myocardial electrical signals during a particular heart rhythm.
Read Report Overview – https://www.transparencymarketresearch.com/3d-cardiac-mapping-systems-market.html
The latest 3D cardiac mapping systems create three dimensional model of any chamber of heart and can track exact location of the catheter. This allows movement of catheters without using an X-ray. 3D cardiac mapping system allows physicians to accurately identify the location of heart chambers that are experiencing arrhythmia.
Increasing incidence of arrhythmia and other cardiac disorders are likely to fuel the demand for 3D cardiac mapping systems technology. In addition, increase in health care expenditure, growing pressure to reduce diagnosis errors, rise in geriatric population, and less time consuming factor are likely to propel the growth of this market. Nevertheless, high cost of the services and limited adoption rate of the system are expected to restrain the market during the forecast period.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=72306
Global 3D Cardiac Mapping Systems Market: Competitive Landscape
Major players have adopted strategies such as partnerships, agreements, new product development, and collaborations to gain competitive advantage in the global 3D cardiac mapping systems market.
In May 2019, Philips and Medtronic, signed a collaboration to extend the business in the cardiac imaging and navigation system segment
In March 2017, Biosense Webster launched Carto 3 system. This advanced 3-D mapping system integrates multiple data sets and images into one resource for highly detailed, real-time information.
Biosense Webster, Inc. (Johnson & Johnson)
Founded in 1847, Biosense Webster, Inc. is a fully owned subsidiary company of Johnson & Johnson. The company is headquartered in New Brunswick, New Jersey, U.S. It markets its products and technologies in the following medical specialties: CARTO System Solutions and non-navigational products.
CARTO System Solutions include CARTO system, therapeutic catheter, ultrasound catheter, and generators
Request for Analysis of COVID-19 Impact on 3D Cardiac Mapping Systems Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=72306
Medtronic Plc
Established in 1949, Medtronic is based in Minneapolis, Minnesota, U.S. The company operates through four main business segments: Cardiac & Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. Medtronic operates in 160 countries across 480 locations globally, serving more than 65 million patients. It holds more than 45,000 patents in the medical technology industry.
Abbott
Founded in 1988, Abbott Laboratories is a medical and pharmaceutical devices company that provides a wide range of diagnostic and medical test instruments used to diagnose and monitor infectious diseases, cancer, heart diseases, and metabolic disorders; and assess other health indicators. The company operates in more than 150 countries through various segments, such as, pharmaceutical products, diagnostic products, nutritional products, and vascular products. The company has developed innovative 3D Cardiac Mapping Systems i.e. ENSITE PRECISION.
Boston Scientific Corporation, Inc.
Founded in 1979, Boston Scientific Corporation is a global medical device company that offers a wide range of medical specialties such as cardiac surgery, vascular surgery, oncology, urology, electrophysiology, endoscopy, and gynecology. The company focuses on developing advanced medical technologies in its core segments such as Cardiovascular, Rhythm Management, and Medsurg. The company has developed cardiac mapping systems such as RHYTHMIA HDx.
Pre Book 3D Cardiac Mapping Systems Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=72306<ype=S
Global 3D Cardiac Mapping Systems Market: Dynamics
Rise in Incidence of Cardiovascular Diseases to Boost Market
Increase in prevalence of arrhythmia and other cardiac disorders is likely to fuel the demand for 3D cardiac mapping systems. The prevalence of cardiac arrhythmia has increased steadily in the past few years due to increased risk of stroke and hospitalizations. This has resulted in increasing demand for devices for the early detection and treatment of cardiac arrhythmia. These factors are likely to drive the 3D cardiac mapping systems market. According to Centers for Disease Control and Prevention (CDC), an estimated 2.7–6.1 million people in the U.S. have Atrial Fibrillation (Arrhythmia).
Focus on Launch of Innovative Products to Boost Market
Manufacturers in the 3D cardiac mapping systems market are strongly focused on increasing investments in research & development activities in order to design and develop new and innovative 3D cardiac mapping systems. For instance, in May 2019, Biosense Webster Inc. launched Cartonet, which is a software that provides cloud-based network for electrophysiologists to analyze, review, and share atrial fibrillation case data to improve procedural efficiency.
More Trending Reports by Transparency Market Research –
Nanotechnology Drug Delivery Market: https://www.biospace.com/article/advances-in-nanotechnology-drug-delivery-models-to-create-new-paradigms-in-cancer-therapeutics/
Digestive Enzymes Market: https://www.biospace.com/article/digestive-enzymes-market-growth-is-expected-to-occur-at-a-healthy-cagr-of-13-1-percent-from-2017-to-2025/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
